Publications by authors named "Keith Davis"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2

Total Likes

1

Extended Reach

1,193

Social Features

5
F
Findings from the Assessment of real-world Disease characteristics and outcomes in Alopecia Areata in a Global non-Interventional Observational cohort (ADAAGIO) study.
Keith L Davis, Andrew Messenger, Sergio Vañó-Galván, Helen Tran, Lynne Napatalung

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe.
Olga Oikonomidou, Mark J Beresford, Elena Galve-Calvo, Achim Woeckel, Rohan C Parikh, Keith L Davis

Breast Cancer Res Treat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata.
Kent A Hanson, Sergio Vañó-Galván, Andrew Messenger, Helen Tran, Lynne Napatalung, Keith L Davis

Dermatol Ther (Heidelb)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia.
Brian Leber, Marcia T Ruiz, Hany Elgendy, Filippa Pettersson, Thomas Prebet, Keith L Davis

Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma.
Jeffrey Weber, Waqas Haque, Svetomir N Markovic, April K S Salama, Inderjit Mehmi, Keith L Davis

Oncologist· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib.
Francesco Passamonti, Siddhi Korgaonkar, Rohan C Parikh, Manoj Chevli, Aylin Yucel, Keith L Davis

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study.
Muhammad Furqan, Siddharth Karanth, Ravi K Goyal, Beilei Cai, Julien Rombi, Keith L Davis

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.
Freny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera, Keith L Davis, Alpesh N Amin

Drugs Real World Outcomes· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer.
Ravi K Goyal, Jingchuan Zhang, Keith L Davis, Martina Sluga-O'Callaghan, Peter A Kaufman

Breast Cancer Res Treat· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma.
Elizabeth Esterberg, Shrividya Iyer, Saurabh P Nagar, Keith L Davis, Nizar M Tannir

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Interconnectedness of Euglycemic Diabetic Ketoacidosis With Concomitant Thyroid Storm: A Case Report.
Kevin D Strawn, Keith W Davis

Cureus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.
Jürgen Wolf, Pierre-Jean Souquet, Koichi Goto, Alexis Cortot, Christina Baik, Keith L Davis

Clin Lung Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy.
Ravi K Goyal, Jingchuan Zhang, Keith L Davis, Martina Sluga-O'Callaghan, Peter A Kaufman

Breast Cancer (Dove Med Press)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis.
Amit G Singal, Saurabh P Nagar, Abby Hitchens, Keith L Davis, Shrividya Iyer

Clin Gastroenterol Hepatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice.
Amit G Singal, Saurabh P Nagar, Abby Hitchens, Keith L Davis, Shrividya Iyer

Cancer Rep (Hoboken)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib.
Paul K Paik, Ravi K Goyal, Beilei Cai, Mark A Price, Keith L Davis

Future Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States.
Reema Mody, Juliana Meyers, Maria Yu, Keith Davis, Joshua A Levine

Curr Med Res Opin· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma.
Gilles Salles, Stephen J Schuster, Martin Dreyling, Luca Fischer, John Kuruvilla, Keith L Davis

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL).
Gilles Salles, Stephen J Schuster, Luca Fischer, John Kuruvilla, Piers E M Patten, Keith L Davis

Hemasphere· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record review.
Francesco Passamonti, Florian H Heidel, Rohan C Parikh, Mayank Ajmera, Derek Tang, Keith L Davis

Future Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing plant-made monoclonal antibodies for research or therapeutic applications.
Kelsi Swope, Josh Morton, Gregory P Pogue, Steve Hume, Michael H Pauly, Keith R Davis

Methods Enzymol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REPRINT OF: Physical and Mental Health Effects of Intimate Partner Violence for Men and Women.
Ann L Coker, Keith E Davis, Ileana Arias, Sujata Desai, Maureen Sanderson

Am J Prev Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the pollution incident performance of water and sewerage companies in England.
Sarah Purnell, Nick Mills, Keith Davis, Christopher Joyce

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance Database.
Juliana Meyers, Meredith Hoog, Reema Mody, Maria Yu, Keith Davis

Clin Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis